FDG-PET/CT vs. Non-FDG Tracers in Less Explored Domains, An Issue of PET Clinics: The Clinics: Internal Medicine, cartea 17-3
Editat de Sandip Basu, Rakesh Kumar, Abass Alavien Limba Engleză Hardback – 20 iun 2022
Din seria The Clinics: Internal Medicine
- 5% Preț: 545.29 lei
- 70% Preț: 186.42 lei
- 5% Preț: 403.22 lei
- 5% Preț: 547.09 lei
- 5% Preț: 547.44 lei
- 5% Preț: 518.41 lei
- 5% Preț: 518.62 lei
- 5% Preț: 518.67 lei
- 5% Preț: 518.96 lei
- 5% Preț: 519.44 lei
- 5% Preț: 517.98 lei
- 5% Preț: 519.60 lei
- 5% Preț: 573.62 lei
- 5% Preț: 403.11 lei
- 5% Preț: 402.77 lei
- 5% Preț: 403.05 lei
- 5% Preț: 282.65 lei
- 5% Preț: 402.97 lei
- 5% Preț: 388.01 lei
- 5% Preț: 463.34 lei
- 5% Preț: 460.60 lei
- 5% Preț: 403.45 lei
- 5% Preț: 405.53 lei
- 5% Preț: 402.77 lei
- 5% Preț: 460.69 lei
- 5% Preț: 462.57 lei
- 5% Preț: 295.31 lei
- 5% Preț: 448.61 lei
- 5% Preț: 402.08 lei
- 5% Preț: 402.52 lei
- 5% Preț: 402.52 lei
- 5% Preț: 519.15 lei
- 5% Preț: 518.39 lei
- 5% Preț: 601.65 lei
- 5% Preț: 518.21 lei
- 5% Preț: 518.09 lei
- 21% Preț: 449.32 lei
- 21% Preț: 448.67 lei
- 5% Preț: 576.44 lei
- 5% Preț: 576.17 lei
- 5% Preț: 577.92 lei
- 5% Preț: 576.94 lei
- 5% Preț: 570.07 lei
- 5% Preț: 576.11 lei
- 5% Preț: 686.25 lei
- 5% Preț: 547.43 lei
- 5% Preț: 745.38 lei
- 5% Preț: 576.27 lei
- 5% Preț: 579.22 lei
Preț: 506.70 lei
Preț vechi: 533.37 lei
-5% Nou
Puncte Express: 760
Preț estimativ în valută:
96.97€ • 100.73$ • 80.55£
96.97€ • 100.73$ • 80.55£
Carte disponibilă
Livrare economică 11-25 ianuarie 25
Livrare express 28 decembrie 24 - 03 ianuarie 25 pentru 202.75 lei
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780323897181
ISBN-10: 0323897185
Pagini: 240
Dimensiuni: 263 x 186 x 20 mm
Greutate: 4.5 kg
Editura: Elsevier
Seria The Clinics: Internal Medicine
ISBN-10: 0323897185
Pagini: 240
Dimensiuni: 263 x 186 x 20 mm
Greutate: 4.5 kg
Editura: Elsevier
Seria The Clinics: Internal Medicine
Cuprins
Facts and Fictions About [18F]FDG versus Other Tracers in Managing Patients with Brain Tumors: It Is Time to Rectify the Ongoing MisconceptionsAn Appraisal and Update of Fluorodeoxyglucose and Non-Fluorodeoxyglucose-PET Tracers in Thyroid and Non-Thyroid Endocrine Neoplasms18F-Fluorodeoxyglucose-PET-Computerized Tomography and non-Fluorodeoxyglucose PET-Computerized Tomography in Hepatobiliary and Pancreatic MalignanciesMolecular Imaging Assessment of Androgen Deprivation Therapy in Prostate CancerMolecular Imaging Assessment of Hormonally Sensitive Breast Cancer: An Appraisal of 2- [18F]-Fluoro-2-Deoxy-Glucose and Newer Non-2-[18F]-Fluoro-2-Deoxy-Glucose PET Tracers18F-FDG Versus Non-FDG PET Tracers in Multiple MyelomaRole of Molecular Imaging with PET/MR Imaging in the Diagnosis and Management of Brain TumorsFibroblast Activation Protein Inhibitor TheranosticsPET-CTBased Quantitative Parameters for Assessment of Treatment Response and Disease Activity in Cancer and Noncancerous DisordersPositron Emission Tomography-Based Assessment of Cognitive Impairment and Dementias, Critical Role of Fluorodeoxyglucose in such SettingsNonmalignant Thoracic Disorders: An Appraisal of Fluorodeoxyglucose and Non>fluorodeoxyglucose PET/Computed Tomography ApplicationsFluorodeoxyglucose PET/Computed Tomography in Evaluation of Prosthetic Joints and Diabetic Foot: A Comparative Perspective with Other Functional Imaging ModalitiesUtility of PET/Computed Tomography in Infection and Inflammation ImagingRole of Fluorodeoxyglucose-PET in Interventional Radiology